Geographical Group Reporting Submission

Group Cochrane Argentina (Universidad del Hospital Italiano de Buenos Aires)

Name Luis Garegnani

Activity name / title Cochrane review update - Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children

Which function does this relate to?

Tier one Promote Cochrane and its work

Tier two Support review production through training and membership

Tier three Act as a coordinating centre for Cochrane activities

Tier four N/A

Evidence production Cochrane review and evidence production

Date

Start date 23-07-2025

Proposed end date 23-07-2025

on-going No

Was this activity in collaboration with other organization(s) or partner(s)? If so which? No

Person to contact if any queries about this activity Luis Garegnani
luisgaregnani@gmail.com

Type of activity Written report or publication

Please give additional activity details (i.e., reach, impact, duration, return on investment) Full review update viewed 2559 since publication in the Cochrane library

Link and documents

Link https://doi.org/10.1002/14651858.CD013757.pub3

By checking this box, my center consents to the use of these photos for Cochrane internal and external purposes, such as websites, reports, social media, etc. Yes